Endothelial 'stunning' following a brief exposure to endotoxin: A mechanism to link infection and infarction?

Cardiovascular Research

Volumn 32, Issue 5, 1996, Pages 822-829

  Bhagat, Kiran ^a,b   Moss, Ray ^a   Collier, Joe ^a   Vallance, Patrick ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

arachidonic acid; endothelium; endotoxins; inflammation; myocardial infarction; nitric oxide

Indexed keywords

ARACHIDONIC ACID; BRADYKININ; ENDOTOXIN; GLYCERYL TRINITRATE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INFLAMMATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADULT; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACID; BACTERIAL INFECTIONS; BRADYKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENDOTOXINS; FEMALE; HAND; HUMANS; HYDROCORTISONE; INFARCTION; MALE; MICROSCOPY, ELECTRON; NITROGLYCERIN; NOREPINEPHRINE; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0030296529     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(96)00123-X     Document Type: Article

References (37)

1. [1] Griffith TM. Modulation of blood flow and tissue perfusion by endothelium-derived relaxing factor. Exp Physiol 1994;79:873-913.
2. [2] Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
3. [3] Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. New Engl J Med 1990;323:27-36.
4. [4] Schini VB, Vanhoutte PM. Role of the L-arginine-nitric oxide pathway in vascular smooth muscle. Eur Heart J 1993;14:S16-S21.
5. [5] Vane JR, Botting RM. Formation by the endothelium of prostacyclin, nitric oxide and endothelin. J Lipid Med 1993;6:395-404.
6. [6] Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med 1993;329:2002-2012.
7. [7] Luizzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. New Engl J Med 1994;331:417-424.
8. [8] Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction. Eur Heart J 1993;14:7-12.
9. [9] Syrjänen J. Infection as a risk factor for cerebral infarction. Eur Heart J 1993;14:12-17.
10. [10] Syrjänen J, Valtonen VV, Iivanainen M, Katse M, Huttunen JK. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle-aged patients. Br Med J 1988;296:1156-1160.
11. [11] Bhagat K, Collier J, Vallance P. Endotoxin-induced venous hyporesponsiveness in humans. Circulation 1996;94:490-497.
12. [12] Collier JG. Veins on the Back of the Hand. Arteries and Veins. London: Churchill Livingstone, 1975; 136-142.
13. [13] Vallance P, Collier J, Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in humans in vivo. Cardiovasc Res 1989;23:1053-1057.
14. [14] Bhagat K, Collier J, Vallance P. Vasodilatation to arachidonic acid in humans: an insight into endogenous prostanoids and effects of aspirin. Circulation 1995;92:2113-2118.
15. [15] Macallister RJ, Calver AL, Riezbos J, Collier J, Vallance P. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery. J Pharmacol Exp Ther 1995;273:154-160.
16. [16] Higman DJ, Powell JT, Greenhalgh RM, Coady A, Moss J. Is thickening of the basal lamina in the saphenous vein a hallmark of smoking? Br Heart J 1994;71:45-50.
17. [17] Shenep JL, Flynn PM, Barrett FF, Stidham GL, Wetenkirchner DF. Serial quantitation of endotoxaemia and bacteraemia during therapy for Gram negative bacterial sepsis. J Infect Dis 1988;157:565-568.
18. [18] Brandtzaeg P, Kierulf P, Gaustad R. Plasma endotoxin as a predictor of multiple organ failure and death in systemic menigococcal disease. J Infect Dis 1989;159:195-204.
19. [19] Moncada S, Vane JR. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull 1978;34:129-135.
20. [20] Parrillo JE. Pathogenetic mechanisms of septic shock. New Engl J Med 1993;328:1471-1477.
21. [21] Snell JR, Parrillo JE. Cardiovascular dysfunction in septic shock. Chest 1991;99:1000-1009.
22. [22] Mamode N, Cobbe S, Pollock JG. Infarcts after surgery. Br Med J 1995;310:1215-1216.
23. [23] Guillen I, Blanes M, Gomez MJ, Castell JV. Cytokine signalling during myocardial infarction: sequential appearance of IL-1 beta and 11-6. Am J Physiol 1995;269:R229-R235.
24. [24] Engstrom L, Torngren S, Rohdin-Alm C. Peroperative endotoxin concentrations in portal and peripheral venous blood in patients undergoing right hemicolectomy for carcinoma. Eur J Surg 1992;158:301-305.
25. [25] Snijdewint FG, Kapsenberg ML, Wauben-Penris PJ, Bos JD. Corticosteroids class-dependently inhibit in vitro Th1-and Th2-type cytokine production. Immunopharmacology 1995;29:93-101.
26. [26] Marx J. How the glucocorticoids suppress immunity. Science 1995;270:232-233.
27. [27] Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclo-oxygenase-2 expression induced by interleukin-1, tumour necrosis factor-alpha, and lipopolysaccharide. J Clin Invest 1995;95:1669-1675.
28. [28] Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumour necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993:205-209.
29. i2, in the promonocytic cell line U937. J Biol Chem 1989;28:3569-3576.
30. [30] Guc O, Furman BL, Parrat JR. Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br J Pharmacol 1990;101:913-919.
31. [31] Baxter GM. Alterations of endothelium-dependent digital vascular responses in horses given low dose endotoxin. Vet Surg 1995;24:87-96.
32. [32] Szabo C, Thiemermann C, Mitchell JA, Vane JR. Activation of constitutive and cytokine-inducible NO synthase accounts for the reduced pressor response to noradrenaline in endotoxic shock. Br J Pharmacol 1992;107:81P.
33. [33] Cook TH, Bune AJ, Taylor M, Loi RK, Cattel V. Cellular localisation of inducible nitric oxide in endotoxic shock in the rat. Clin Sci 1994;87:179-186.
34. [34] Parker JL, Myers PR, Zhong Q, Kim K, Adams HR. Inhibition of endothelium-dependent vasodilatation by Escherichia coli endotoxaemia. Shock 1994;2:451-458.
35. [35] Baigrie RJ, Lamont PM, Whiting S, Morris PJ. Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg 1993;166:248-251.
36. [36] Casey WF, Hauser GJ, Hannallah RS, Morris FM, Khan WN. Circulating endotoxin and tumour necrosis factor during paediatric surgery. Crit Care Med 1992;20:1090-1096.
37. [37] Luscher TF, Noll G. Endothelial dysfunction in the coronary circulation. J Cardiovasc Pharmacol 1994;24:S16-S26.